54 engineering-computation-"https:"-"https:"-"https:"-"https:"-"https:"-"Fraunhofer-Gesellschaft" positions at Ulster University
Sort by
Refine Your Search
-
glioblastoma (GBM) patient-derived tumour models using an engineered extracellular matrix (ECM) tissue mimic hydrogel system and HTP 3D bioprinting. Gene expression analysis from a GBM patient cohort will be
-
, design, and problems, Heliyon, 2023. Zhao et al. Patient-specific computational simulation of coronary artery bifurcation stenting, Scientific Reports, 2021. Khan et al. 3D printing technology and its
-
approaches often provide only limited insight into these effects. This project will use advanced computer simulation, informed by post-operative scans and patient movement data, to understand how variations in
-
of Structural Composites, Woodhead Publishing Series in Composites Science and Engineering 2023, Pages 189-206 Golbang, A. et. al. https://pure.ulster.ac.uk/en/publications/study-of-two-anti-biofouling-strategies
-
Summary The Law research unit at Ulster University invites PhD proposals from applicants in our emerging research specialisms of legal technology, ethics and medical law. Ulster’s Centre for Legal
-
. This project is available in the Computer Science Research Institute and is tenable in the Faculty of Computing, Engineering and the Built Environment, at the Magee campus. The PhD researcher will be based
-
opportunities to be active. There are a number of PL programmes to support physical literacy and motor skills in children, however, the next step is to explore how this programme could also work for children with
-
intraoperative feedback on these risks. The project will combine biomedical engineering, signal processing, and clinical collaboration to design a non-invasive ultrasound monitoring system capable of quantifying
-
clinical translation of this technology and (3) expedite commercial exploitation of this technology. Specific objectives: To generate a range of tumour tissue samples from in vivo models treated with SGEN-33
-
Summary Applicants are invited to undertake a 3 year PhD program in partnership with a global leader in blood- and cell-based therapies (Terumo Blood and Cell Technologies Ltd). This opportunity